EPS Bio Technology Corp.(TW:4183)
NT$14.500.00 (0.00%)
TW:4183
EPS Bio Technology Corp. financials statements
NT$14.50
At close:0.00 (0.00%)
EPS Bio Technology Corp. (4183) Income Statement
EPS Bio Technology Corp. Income Statement
Last quarter (Q2 2026), EPS Bio Technology Corp.'s total revenue was NT$105.58M, a decrease of 18.96% from the same quarter last year. In Q2, EPS Bio Technology Corp.'s net income was NT$-1.47M. See EPS Bio Technology Corp.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 499.70M | NT$ 451.08M | NT$ 470.17M | NT$ 463.45M | NT$ 480.28M | |
| NT$ 81.93M | NT$ 96.27M | NT$ 115.71M | NT$ 107.42M | NT$ 120.67M | |
| NT$ 91.03M | NT$ 92.76M | NT$ 90.79M | NT$ 88.80M | NT$ 86.41M | |
| Depreciation and Amortization | NT$ 15.38M | NT$ 14.60M | NT$ 15.49M | NT$ 17.31M | NT$ 18.58M |
| NT$ 6.29M | NT$ 34.46M | NT$ 44.09M | NT$ 49.50M | NT$ 45.49M | |
| NT$ -9.10M | NT$ 3.51M | NT$ 24.92M | NT$ 32.20M | NT$ 26.91M | |
| NT$ -572.00K | NT$ 12.41M | NT$ 1.54M | NT$ 11.44M | NT$ -9.53M | |
| NT$ -9.67M | NT$ 17.81M | NT$ 26.46M | NT$ 27.46M | NT$ 23.52M | |
| NT$ -7.87M | NT$ 17.31M | NT$ 20.99M | NT$ 25.36M | NT$ 18.64M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -0.33 | NT$ 0.73 | NT$ 0.88 | NT$ 1.07 | NT$ 0.78 |
| Diluted EPS | NT$ -0.33 | NT$ 0.73 | NT$ 0.88 | NT$ 1.06 | NT$ 0.78 |
| Weighted Average Shares Outstanding | 23.80M | 23.86M | 23.85M | 23.80M | 23.80M |
| Weighted Average Shares Outstanding (Diluted) | 23.80M | 23.86M | 23.87M | 23.87M | 23.89M |
Currency in TWD

